RBC Capital lowered the firm’s price target on Bausch Health (BHC) to $8.50 from $9 and keeps a Sector Perform rating on the shares. The firm adjusts its model to reflect the recent sizable debt financing and the valuation of comps, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Bausch Health Upsizes Private Offering to $4.4 Billion
- Bausch Health Announces Conditional Redemption of Senior Notes
- Raymond James sees positive reaction in Bausch Health shares in next days
- Bausch Health Launches $4 Billion Note Offering to Restructure Debt
- Bausch Health Launches $3.8 Billion Credit Facilities Syndication